X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ABBOTT INDIA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ABBOTT INDIA FULFORD INDIA/
ABBOTT INDIA
 
P/E (TTM) x 398.8 43.2 922.6% View Chart
P/BV x 6.2 10.8 57.6% View Chart
Dividend Yield % 0.1 0.6 13.6%  

Financials

 FULFORD INDIA   ABBOTT INDIA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ABBOTT INDIA
Mar-16
FULFORD INDIA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs9426,015 15.7%   
Low Rs4503,707 12.1%   
Sales per share (Unadj.) Rs691.41,236.9 55.9%  
Earnings per share (Unadj.) Rs11.5122.2 9.4%  
Cash flow per share (Unadj.) Rs15.4129.0 11.9%  
Dividends per share (Unadj.) Rs2.0035.00 5.7%  
Dividend yield (eoy) %0.30.7 39.9%  
Book value per share (Unadj.) Rs380.0521.2 72.9%  
Shares outstanding (eoy) m3.9021.25 18.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.9 25.6%   
Avg P/E ratio x60.739.8 152.6%  
P/CF ratio (eoy) x45.337.7 120.2%  
Price / Book Value ratio x1.89.3 19.6%  
Dividend payout %17.428.6 60.9%   
Avg Mkt Cap Rs m2,714103,296 2.6%   
No. of employees `0000.43.0 15.0%   
Total wages/salary Rs m5053,370 15.0%   
Avg. sales/employee Rs Th6,073.08,891.8 68.3%   
Avg. wages/employee Rs Th1,137.41,140.0 99.8%   
Avg. net profit/employee Rs Th100.7878.3 11.5%   
INCOME DATA
Net Sales Rs m2,69626,284 10.3%  
Other income Rs m125504 24.9%   
Total revenues Rs m2,82226,789 10.5%   
Gross profit Rs m-463,665 -1.3%  
Depreciation Rs m15144 10.5%   
Interest Rs m108 117.3%   
Profit before tax Rs m544,017 1.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m101,421 0.7%   
Profit after tax Rs m452,596 1.7%  
Gross profit margin %-1.713.9 -12.3%  
Effective tax rate %17.735.4 50.0%   
Net profit margin %1.79.9 16.8%  
BALANCE SHEET DATA
Current assets Rs m1,73814,446 12.0%   
Current liabilities Rs m5454,725 11.5%   
Net working cap to sales %44.337.0 119.7%  
Current ratio x3.23.1 104.4%  
Inventory Days Days4851 94.3%  
Debtors Days Days420 22.0%  
Net fixed assets Rs m121,113 1.1%   
Share capital Rs m39213 18.4%   
"Free" reserves Rs m1,44310,808 13.4%   
Net worth Rs m1,48211,076 13.4%   
Long term debt Rs m00-   
Total assets Rs m2,07716,241 12.8%  
Interest coverage x6.7497.0 1.4%   
Debt to equity ratio x00-  
Sales to assets ratio x1.31.6 80.2%   
Return on assets %2.616.0 16.3%  
Return on equity %3.023.4 12.9%  
Return on capital %4.336.3 11.8%  
Exports to sales %00.6 0.0%   
Imports to sales %24.512.6 193.4%   
Exports (fob) Rs mNA162 0.0%   
Imports (cif) Rs m6593,322 19.8%   
Fx inflow Rs m17268 6.4%   
Fx outflow Rs m6733,927 17.1%   
Net fx Rs m-656-3,659 17.9%   
CASH FLOW
From Operations Rs m902,514 3.6%  
From Investments Rs m105-800 -13.1%  
From Financial Activity Rs m-14-803 1.8%  
Net Cashflow Rs m181912 19.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 3.8 7.9 48.1%  
FIIs % 0.1 0.1 100.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 17.1 124.0%  
Shareholders   4,783 18,270 26.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   TORRENT PHARMA  NATCO PHARMA  BIOCON LTD  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS